The American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Symposium is a pivotal event in the oncology calendar, bringing together experts from around the world to share groundbreaking research and insights into gastrointestinal cancers. As we look ahead to 2025, it’s essential for researchers and clinicians alike to mark their calendars with key deadlines that could shape their participation in this influential gathering.
For those eager to present their findings at the upcoming ASCO GI 2025, which will take place from January 23-25 in San Francisco, the abstract submission process has already begun. The deadline for submitting abstracts is set for September 24, 2024, at 11:59 PM Eastern Time. This date marks a crucial opportunity for researchers to showcase new studies related to gastrointestinal cancers—ranging from innovative treatment strategies to novel clinical observations.
In addition, there’s an important note regarding Late-Breaking Abstracts (LBA). If you have preliminary data that emerges after the initial submission deadline but holds significant potential impact on clinical practice or presents novel findings worthy of immediate attention, these can be submitted until October 24, 2024. However, remember that LBA submissions must first secure a placeholder by meeting the earlier September deadline.
When preparing your abstract submissions:
- Ensure your work addresses relevant scientific questions within gastroenterology and includes original data or substantial updates on ongoing research.
- Each abstract should not exceed approximately 2600 characters and may include one table summarizing critical results.
- Be mindful of authorship limits; each submission can list up to twenty authors only.
- Importantly, any content presented at ASCO GI cannot be disclosed publicly before its official presentation during the conference itself—a rule designed to maintain integrity within academic discourse.
As excitement builds towards this annual symposium dedicated solely to advancements in gastrointestinal cancer care and research methodologies, it's vital not just for seasoned professionals but also emerging voices in oncology medicine who wish their contributions heard loud and clear amidst global discussions surrounding cancer treatments.